ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STX Shield Therapeutics Plc

1.725
-0.075 (-4.17%)
Last Updated: 08:16:52
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.075 -4.17% 1.725 1.70 1.75 1.80 1.725 1.80 835,518 08:16:52
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.33 13.34M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.80p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £13.34 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.33.

Shield Therapeutics Share Discussion Threads

Showing 3576 to 3597 of 23425 messages
Chat Pages: Latest  145  144  143  142  141  140  139  138  137  136  135  134  Older
DateSubjectAuthorDiscuss
14/7/2019
09:58
Few things could really play out here

Get FDA approval hopefully. This will attract in Institutional investment.
Rising share price leading to...
Private investors will get Shield on their radar and do a bit of investigation and realise
China potential
Takeover potential
PT 20 potential

All this feeds itself into an ever increasing share price hopefully for all current and future holders

peachie 74
14/7/2019
09:28
Of which Shield are predicting 200 million turnover on their website
peachie 74
14/7/2019
08:52
I guess we might get some news in PT20 soon?

Its next product, PT20, an iron-based phosphate binder for treatment of a complication of advanced renal disease, is preparing for patients stage trials.

ny boy
13/7/2019
20:30
If they get fda approval, any “opportunist” is going to have to make a big price bid, otherwise, why bother selling out, STX will tie up a big license partner and watch the funds roll in 🎰🎰🎰
ny boy
13/7/2019
18:57
Currently the market cap is £135 million. Clearly there is still a very small risk of push back from the FDA but assuming it is approved that is ridiculously low. A drug addressing a billion dollar market approved in the US and Europe has to be worth substantially more than that, although of course it is debatable what market share they will take. The US commercial deal will follow on shortly after approval plus there is a deal in China to come so loads to look forward to in the short and medium term.

You have to say the major risk here is an opportunistic acquisition probably from whatever company is looking to license Ferracru in the US. Hopefully they will wait a couple of years before they make a move. I was discussing this situation with a CFO of a biotech I know well from my Pharma career last week and he said that he thought this was the most likely scenario.

Whatever happens the future looks very bright for STX shareholders!

nobbygnome
13/7/2019
16:31
Next week will see a steady 2-3p per share rise each day next week. Then when announcement is made on 26 or 29 July, I see the share price hit 202 - 217 range and then steady at 205 until mid August and next news on sales and distribution.
97peter
13/7/2019
01:18
TBF at least the price hasn’t dropped.
The misrepresentation of buys and sells though does influence the market , so is irritating.
The introduction of institutional buyers once FDA approval granted ( they will put money in long term, not gamble on a decision) will mean the price will rise rapidly.
Very interesting 2 weeks coming up !

peachie 74
12/7/2019
21:13
Summer market manipulation, they are still trying to mug more and steal their shares, this is only going one way 📈
ny boy
12/7/2019
21:11
The algorithm just looks at the price relative to the spread and then calls a buy or a sell. So the curious aspect is why are the MM selling buyers shares at the bid price. That suggests they do have shares to offload...
nobbygnome
12/7/2019
20:16
Totally peache, why are the brokers and markets showing buys as sells??? My daughter bought 3497 shares at 1600 today as a buy, but it showed as a sell on Interactive at 115p ??? Why oh why?? This was a blatant buy, what are they trying to do, stop a hike to 155p, before the 19 July????
97peter
12/7/2019
18:24
35,000 @ 110p, surely not another delayed sell from the other day? Looks like a buy, who would be mad enough to sell now, especially now the bid is 115p doh and double doh! 🤦🏻‍♂️🤦🏻‍♂️
ny boy
12/7/2019
15:51
Just about every buy showing as a sell !!
peachie 74
12/7/2019
14:44
Can’t be long before we get some broker noises out before 27 July.

Summer volumes but very few want to sell now, there is a high probability of fda approval


Yes CNA, surely you have heard of them, I took a spread bet long @ 87p £50pp and a few shares as well.

ny boy
12/7/2019
14:04
Or could be Friday 26 for max impact, assuming all good with out friends in the US!

Ouch 10,000 sell @ 108p, another right royal mugging from the other day.. doh!



No knowing,not in those,more into divi earners IAG,BAB and just started to nibble at CNA, just to balance the portfolio.

ny boy
12/7/2019
12:26
NY B hope you took a few PHD
knowing
12/7/2019
12:11
Having done a little more research I decided to add a few more at 115 as I think you are right best1467. It's showing as a sell again !! Lets hope the FDA approval is the icing on the cake.
machinist
12/7/2019
11:52
Not sure that this company should be looked as a gamble investment even without fda approval first time around we should continue to see significant growth from Europe and Switzerland with the China deal to come which could arrive at anytime
best1467
12/7/2019
11:24
Welcome machinist.

Not so much a toss of a coin, as they are already selling Feraccru in the E.U.,UK & Switzerland

It seems quite likely they will get fda approval, it’s not a given of course, if they do get fda approval,the prospects going forward will be huge, if that happens I will just hold the shares for a longer term and go traveling the World. The share price nos could be huge over time and with China next.

ny boy
12/7/2019
10:27
Hi, just taken a small punt on this one with funds rescued from TCG. Thought I would loose it anyway if I stayed with Thomas Cook so might as well take a gamble her. Complete toss of a coin choice here LOL

My buy is showing as a sell as the rest seem to be this morning.

machinist
12/7/2019
09:29
Some buys (115.4) showing as sells this am
peachie 74
12/7/2019
09:28
A few buys and this will start motoring.
Wish I had a bit in the kitty at that spread !

peachie 74
12/7/2019
09:07
Closest spread ever sell 115.3/115.4 buy!

Trying to seduce investors to sell, not much stock around, majority holding for the main event.

ny boy
Chat Pages: Latest  145  144  143  142  141  140  139  138  137  136  135  134  Older

Your Recent History

Delayed Upgrade Clock